Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sneha V Gupta

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Nano|November 12, 2015
Determining the Time Window for Dynamic Nanowire Cell Penetration ProcessesXi Xie, Amin Aalipour, Sneha V Gupta, et al.
Phytotherapy Research : PTR|January 3, 2013
Potentiating effect of the flavonolignan (-)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell lineLynette Bueno Pérez, Li Pan, Ellen Sass, et al.
Drugs in R&D|November 6, 2021
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV InfectionSneha V Gupta, Marie C Fanget, Christopher MacLauchlin, et al.
Plos Medicine|April 3, 2019
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimizationNatasha Strydom, Sneha V Gupta, William S Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cellsSneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
The AAPS Journal|April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometryU V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
The AAPS Journal|May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cellsSneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Nano|November 12, 2015
Determining the Time Window for Dynamic Nanowire Cell Penetration ProcessesXi Xie, Amin Aalipour, Sneha V Gupta, et al.
Phytotherapy Research : PTR|January 3, 2013
Potentiating effect of the flavonolignan (-)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell lineLynette Bueno Pérez, Li Pan, Ellen Sass, et al.
Drugs in R&D|November 6, 2021
Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV InfectionSneha V Gupta, Marie C Fanget, Christopher MacLauchlin, et al.
Plos Medicine|April 3, 2019
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimizationNatasha Strydom, Sneha V Gupta, William S Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cellsSneha V Gupta, Erin Hertlein, Yanhui Lu, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
The AAPS Journal|April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometryU V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
The AAPS Journal|May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cellsSneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Blood|June 29, 2012
ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridolEmilia Mahoney, David M Lucas, Sneha V Gupta, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Pageof 2